Oncologists from NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine will discuss their latest research findings at the American Society for Clinical Oncology (ASCO) annual meeting, June 3-7 in Chicago. The presentations will cover a variety of disciplines and treatment approaches, with a focus on this year's meeting theme: the future of patient-centered care and research.
Among the institutions' total of 48 sessions, two abstracts have been selected for inclusion in the Best of ASCO program, which highlights the most cutting-edge science and research presented at the meeting. Dr. Dawn Hershman, leader of the Breast Cancer Program of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center, will discuss the risk of neuropathy in patients receiving chemotherapy, and Dr. Adrienne Phillips, assistant professor of medicine at Weill Cornell Medicine and assistant attending physician at NewYork-Presbyterian/Weill Cornell Medical Center, will present information about a novel antibody that combats CCR4 in adult T-cell lymphoma.
Research links COVID-19 vaccines to temporary facial palsy in over 5,000 patients